Torna indietro Torna alle Linee Guida

Torna indietro Home 


 Bibliografia sull'ADHD

 


Achembach T. Manual for the Child Behaviour CheckList/ 4-18 and 1991 profile. Burligton, University of Vermont, 1991.

American Academy Child & Adolescent Psychiatry. Practice parameters for the assessment and treatment of Attention Deficit Hyperactivity Disorder. J Am Acad Child Adolescent Psychiatry 1997; 36: 85S-121S.

American Academy Child & Adolescent Psychiatry. Practice parameters for the use of stimulant medication in children, adolescent and adults. J Am Acad Child Adolescent Psychiatry 2002; 41: 26S-49S

American Academy of Pediatrics. Clinical Practice Guideline: Treatment of school-aged child with Attention Deficit Hyperactivity Disorder. Pediatrics 2001; 108: 1033-1044.

American Academy of Pediatrics. Diagnostic evaluation of the child with Attention Deficit Hyperactivity Disorder. Pediatrics 2000; 105: 1158-1170.

American Psychiatric Association, Diagnostic and Statistical Manual of mental Disorders, 4th ed (DSM-IV). Washington, DC: American Psychiatric Association. 1994.

Andersen SA, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon Jr. WA. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nature Neuroscience 2002; 5:13-14.

Arnsten AF. Genetics of childhood disorders: XVIII. ADHD, Part. 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 2000;39:1201-3.

Arnsten AF, Steere JC, Hunt RD. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry  1996;53: 448-55.

Barkley RA Handbook of attention deficit disorder 2nd ed. New York Guilford 1998

Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997; 121: 65-94.

Barkley RA, Guevremont DC, Anastopoulos AD.  et al. A comparison of three family therapy programs for treating family conflicts in adolescents with ADHD.  J. Consult. Clin. Psychol. 1992; 3: 450-462.

Barkley R.A., McMurray M.B., Edelbroch C.S., Robbins K. Side effects of methylphenidate in children with ADHD: systemic, placebo-controlled evaluation. Pediatrics 1990;  86: 184-192.

Barr CL. Genetics of childhood disoders: XXII.adhd, part 6: the dopamine D4 receptor gene J Am Acad Child Adolescent Psychiatry 2001; 40: 118-121.

Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther. 1987; 242: 911-916.

Bradley C. The behaviour of children receiving benzedrine. Am. J. Psychiatry 1937; 94: 577-585.

Biederman J., Wilens T.,, Mick E., Spencer T, Faraone SV. Pharmacotherapy of attention defict-hyperactivity disorder reduce risk for substance use disorder . Pediatrics 1999; 104: e20*.

Biederman J. Spencer TJ. Genetics of childhood disorders: XIX. ADHD, Part. 2: is ADHD a noradrenergic disorder? J Am Acad Child Adolesc Psychiatry 2000;39: 1330-1333.

Bloom DR, Levin HS, Ewing-Cobbs L; Lifetime and novel psychiatric disorders after pediatric traumatic brain injury.J. Am. Acad Child Adolesc. Psychiatry  2001; 40: 572-579.

Buitelaar J, Van deer Gaag RJ, Swaab-Barneveld H, Kuiper M. Prediction of clinical response of methylphenidate children with in Attention Deficit-Hyperactivity Disorder J. Am. Acad Child Adolesc. Psychiatry 1995; 34: 1025-1032.

Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J. Anterior cingulate cortex dysfunction in attention deficit /hyperactivity disorder revealed by fMRI and counting Stroop. Biol. Psychiatry 1999; 45: 1542-1552.

Camerini G, Coccia M, caffo E. Il Disturbo da Deficit dell’Attenzione-Iperattività: analisi della frequenza in una popolazione scolastica attraverso questionari agli insegnanti. Psichiatria dell’infanzia e dell’adolescenza, 1996; 63: 587-594

Cantwell D.P. Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996; 35, 978-987.

Casey B.J., Castellanos F.X., Giedd J.N., et al. Implication of right frontostriatal circuitry in response inhibition and attention -deficit hyperactivity disorder. J. Am Acad. Child Adolesc. Psychiatry 1997; 36: 374-383.

Castellanos FX, Lau E, Tayebi N, et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry  1996; 53: 607-616.

Cianchetti C, Sannio-Fancello G. Scale di Autosomministrazione per il fanciullo e l’Adolescente (SAFA) Organizzazioni Speciali, Firenze. 2001

Cook E.H., Stein M.A., Krasowski M.D., et al. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 1995; 56, 993-998.

Conners CK. Conners’ rating scales- Revised. Technical manual  Multi-Health System, Toronto, Canada,1997

Conners CK, Epstein JN, March JS, Angold A et al.  Multimodal treatlment of ADHD in the MTA: an alternative analysis. . J Am Acad Child Adolescent Psychiatry 2001; 40: 159-167.

Dunnick JK, Hailey JR. Experimental studies on the long-term effects of methylphenidate hydrochloride. Toxicology  1995; 103: 77-84

Doyle AE, Biederman J, Seidman LJ, Weber W, Faraone SV. Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit-hyperactivity disorder. J Consult Clin Psychol. 2000; 68: 477-488

DuPaul GJ, Barkley RA, Anastopoulos  AD, Reid R. ADHD Rating scale -IV.Checklisti, norms and clinical Interpretation. Guilford, New York 1998.

Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention deficit hyperactivity disorder. New Engl.J.Med. 1999; 340: 780-788.

Faraone SV, Doyle AE, Mick E, Biederman J. Meta-Analysis of the Association Between the 7-Repeat Allele of the Dopamine D4 Receptor Gene and Attention Deficit Hyperactivity Disorder . Am. J. Psychiatry 2001; 158:1052–1057.

Filipek PA, Semrud-Clikeman M, Steingard RJ et al.. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997; 48: 589-601.

Fisher SE, Francks C, McCracken JT. Et al, A Genomewide Scan for Loci Involved in Attention-Hyperactivity Disorder Am. J. Hum. Genet. 2002; 70:1183–1196.

Firestone P. Kelly MJ, Goodman JT et al. Differential effects of parent training and stimulant medicationwith hyperactives. J. Am. Acad Child Adolesc. Psychiatry  1981; 20: 135-147.

Firestone P. Crowe D, Goodman JT Vicissitudes of follow-up studies: differential effects of parent training and stimulant medication with hyperactives. Am.J. Ortopsychiatry  1986; 56: 185-194.

Frowein, HW. Selective effects of barbiturate and amphetamine on information processing and response execution. Acta Psychologica. 1981; 47: 105-115.

Gadow KD., Nohal EE., Sverd J., Sprakkin J, Paolicelli L. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 1990; 29, 710-715.

Gallucci F, Bird HR, Berardi C, et al.. Symptoms of Attention deficit hyperactivity disorder in an Italian school sample: finding of a pilot study. J. Am. Acad. Child Adolesc. Psychiatry  1993; 32, 1051-1058.

Gillberg C., Melander H., von Knorring A-L. et al. Long-term stimulant treatment of children with attention deficit hyperactivity symptoms. Arch Gen Psychiatry  1997; 54, 857-864.

Goldman-Rakic P.S. Dopamine mediated mechanism of prefrontal cortex. Semin Neurosci. 1992; 4: 149-159.

Guevara JP, Stein MT. Evidence based management of attention deficit hyperactivity disorder. Br Medical Journal. 2001;323:1232-1235.

Highfield DA, Hu D, Amsel A. Alleviation of x-irradiation-based deficit in memory-based learning by D-amphetamine: Suggestions for attention deficit– hyperactivity disorder. Proc. Natl. Acad. Sci. USA 1998; 95: 5785–5788

Hill P, Taylor E. An auditable protocol for treating attention deficit/hyperactivity disorder. Arch. Dis. Child 2001; 84: 404-409.

Horn WF, Ialongo N, Pascoe JM. Addictive effects of psychostimulants , parent training and self-control therapy with ADHD children: a 9 months follow-up. J. Am. Acad Child Adolesc. Psychiatry 1991; 32: 182-189.

Kovacs M. Children Depression Inventory, Multi Health System, Toronto , Canada, 1992.

LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1:121-124.

Hechtman L. Assessment and diagnosisi of Attention-Deficit/Hyperactivity Disorder. In: Stubbe DE (ed.) Attention-Deficit/Hyperactivity Disorder . Child Adolesc. Clin. North America 2000; 9: 481-498.

Horrigan JP, Barnhill LJ. Guanfacine and secondary mania in children. J Affect Disord 1999;54:309-314

International Consensus Statement on ADHD European Child & Adolescent Psychiatry  2002; 11: 96-98.

Lonigan CJ, Elbert JC, Johnson SB; Empirically supported psychosocial interventions for children. J.Clin. Child Psychol. 1998; 27: 138-145.

Lou HC, Andresen J, Steinberg B, McLauglin T, Friberg L. The striatum in a putative cerebral network  activated by  verbal  awareness in normal and ADHD children. Eur. J. Neurol. 1998; 5: 67-64.

Jaffe SL. Failed attemps at intranasal abuse of Concerta. J Am Acad Child Adolesc Psychiatry 2002; 41: 5.

Jensen PS, Mrazek D, Knapp PK et al. Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation.  J Am Acad Child Adolesc Psychiatry 1997; 36: 1672-1679.

Jensen PS . Attention-Deficit/Hyperactivity Disorder: concepts on etiology, pathophysiology and neurobiology. In: Stubbe DE (ed.) Attention-Deficit/Hyperactivity Disorder . Child Adolesc. Clin. North America 2000; 9: 557-572.

Joughin C, Zwi M.FOCUS on the use of stimulants in children with Attention-Deficit/Hyperactivity Disorder. Primary evidence-based Briefing n.1. College research Unit. Royal College of Psychiatrist London. 1999.

Kanotchvil CJ, Bohac D, Harrington M, Baker N, May D, Burke WJ. An open label trial with tomoxetine in pediatric attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacology 2001; 11: 167-170.

Kernberg P F, Chazan SL, Normandin L, The Children’s Play Therapy Instrument (CPTI) Journal of Psychotherapy Practice and Research, 1998; 7: 196-207

King R A and The Work Group on Quality Issues, Practice Parameters for the Psychiatric Assesment of Children and Adolescents. J. Am. Acad. Child Adolesc. Psychiatry, 1995; 31:1386-1402./ J. Am. Acad. Child Adolesc. Psychiatry, 1997; 36(10 Supplement):4S-20S (reprint)

Klorman R., Brugmaghim JT., Fitzpatrick PA., Borgstedt AD. Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during continuous performance test. J Abnorm Child Psychol 1991; 19: 263-283.

Komrad K, Gauggel S, Manz A. Scholl M. Inhibtory control in children with traumetic brain Injury (BTI) and children with attention defict/hyperactivity disorder (ADHD). Brain Inj. 2000; 14: 859-875.

Mahalick DM, Carmel PW, Greenberg JP. Et al. Psychopharamcologic treatment of acquired attention disorders in children with brain injury. Pedistr. Neurosurg. 1998; 29: 121-126.

Mannuzza S., Klein R.G., Bessler A., Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am. J. Psychiatry  1993; 155: 493-498.

Mannuzza S., Klein R.G. Longterm prognosis of Attention-Deficit/Hyperactivity Disorder. In: Stubbe DE (ed.) Attention-Deficit/Hyperactivity Disorder . Child Adolesc. Clin. North America 2000; 9: 711-726.

March J. Multidimensional anxiety Scale for Children, Multi Health System Inc. Toronto, Canada, 1997

Marzocchi G. M., Di Pietro M., Bassi E., Filoramo G., Salmaso A. (inviato per la pubblicazione). A behavioral training for managing inattention, hyperactivity and oppositional behaviors at school.

Marzocchi GM, Oosterlaan J, DeMeo T, Di Pietro M, Pezzica S, Cavolina P, Sergeant JA, Zuddas A. Scala di valutazione dei Comportamenti Dirompenti per insegnanti (SCOD-I): validazione e standardizzazione di un questionario per la valutazione dei comportamenti dirompenti a scuola. Giorn. Neuropsichiatria Età Evol. 2001; 21, 378-393.

Marzocchi G.M., Oosterlaan J., De Meo T., Di Pietro M., Pezzica S., Cavolina P., Sergeant J.A., Zuddas A. (inviato per la pubblicazione). Comportamenti di disattenzione, iperattività e oppositività secondo i genitori: un questionario per la valutazione dei comportamenti dirompenti (SCOD-G) in età evolutiva.

Mataro M, Garcia-Sancuez C, Junque C, Estevez-Gonzales A, Pujul J. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch. Neurol. 1997; 54: 963-968.

Mehta MA, Owen AM, Sahakain BJ,  et al. Methylphenidate enhance working memory by modulating discrete frontal and parietal lobe region in the human brain. J.Neuroscience 2000; 20: RC65 (1-6)*.

Michelson D, Faries D, WernickeJ, Kelsey D,  Kendrick K, Sallee FR, Spencer T, Atomoxetine Study Group. Atomoxetine treatment of children and adolescents with attention-deficit hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 2001; 108: E83*

MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives General Psychiatry 1999; 56: 1073-1086;

MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/ hyperactivity disorder. Archives General Psychiatry 1999; 56: 1088-1096.

Musten LM, Firestone P, Pisterman S, Bennet S, Mercer J. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. J Am Acad Child Adolesc Psychiatry 1997; 15: 1407-1415.

National Institute for Clinical Excellence. Guidance on the use of Methylphenidate (Ritalin, Equasym) for Attention Deficit Hyperactivity Disorder. 2000 (www.nice.org.uk)

National Institues of Health Consencus  Development Conference Statemet on “Diagnsi and treatment of Attention-Deficit/Hyperactivity disorder 1998 http://odp.od.nih.gov/consensus/cons/110/110_statement.htm

O’Toole K., Abramowitz A., Morris R, Dulcan M. Effects of methylphenidate on attention and nonverbal learning in children with ADHD. J Am Acad Child Adolesc Psychiatry 1993; 36: 531-538.

Pelham W, Gnagy EM, Greenslade KE, Milich R. Teacher Ratings of DSM-III-R Symptoms for the Disruptive Behaviour Disorders. Journal of American Academy of Child and Adolescent Psychiatry 1992; 31: 210-218.

Pelham WE Jr., Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J.Clin. Child Psychol. 1998; 27: 190-205.

Pelham WE Jr, Hoza B; Comprehensive treatment for ADHD: a proposal for intensive summer treatment programs and outpatient follow-up. In: Hibbs E, Jensen p (eds) Psychosocial treatment research of children and adolescent disorders. Washington DC, America Psychiatric Press 1996, pp. 311-340

Pelham WE Jr, Hinshaw S. Handobook of Clinical Behavioral Therapy, New York, Wiley 1992

Pelham W, Gnagy EM, Burrows-Maclean L et al. Once-a-day Concerta methylfenidate versus three-times-dayly methylfenidate in laboratory and natural setting. Pediatrics 2001 107: E 105 *

Pfiffner LJ, McBurnett K, Social skill trainig with parent generalization: treatment effects for children with ADD/ADHD.  J. Consult. Clin. Psychol.  1997; 65: 749-757.

Pisterman S, Firestone P, Mc Grath P et al. Outcome of parent training in the therapy of preschooler with ADHD. Am.J. Ortopsychiatry  1992; 62: 397-408.

Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry. 1996; 35: 264-272.

Pochon JB, Levy R, Fossati P , Lehericy S, et al. The neural system that bridges reward and cognitionin humans: An fMRI study 2002; Proc. Natl.Acad.Sci. USA 2002; 99: 5669–5674

Posner M.I. and Peterson S.E. The attention system of the human brain. Ann Rev Neurosci 1990; 13: 25-42.

Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2000; 10: 193-204.

Quay HC. Theories of ADDH. J Am Acad. Child Adolescent  Psychiatry 1988; 27: 262-263.

Quay HC. Inhibition and attention deficit hyperactivity disorder. J Child Psychol. Psychiatry 1997, 25: 7-13.

Rapoport J.L. and Castellanos F.X. Attention deficit hyperactivity disorder. In J.M. Weiner (Ed) Diagnosis and psychopharmacology of childhood and adolescent disorders. 2th ed. New York: Wiles & Sons. 1996; pp. 265-280.

Reich W. Diagnostic Interview for Children and Adolescents (DICA). J Am Acad. Child Adolescent  Psychiatry 2000;39:59-66.

Richter JE, Arnold LE Jensens et al. NIMH collaborative multisite,  multimodal treatment study of Children with ADHD; I. Background and rationale. J Am Acad. Child Adolescent  Psychiatry  1995; 34: 987-1000.

Rubia K, Taylor E, Smith AB, Oksannen H, Overmeyer S, Newman S. Neuropsychological analyses of impulsiveness in childhood hyperactivity. Br. J. Psychiatry 2001; 179: 138-143.

Sanders, AF. Elements of human performance: Reaction processes and attention in human skill. Lawrence Erlbaum. 1998; Mahwah, NJ.

Santosh PJ, Taylor E. Stimulant Drugs . Eur. J. Child Adolesc. Psychiatry 2000; 9 (suppl.1) 27-43.

Schachar, R., Logan, G. Are hyperactive children deficient in attentional capacity? J. Abnormal Child Psychology 1990; 1: 493-513.

Schachar R, Tannock R, Cunningham C, Corkum P; Behavioral, siyuational and temporal effects of treatment of ADHD  with methylfenidate. J Am Acad Child Adolesc Psychiatry 1997; 36: 754-763.

Schachar R, Taylor E., Wieselberg M., Thorley G. and Rutter M. Changes in family function and relationships in children who respond to methylphenidate. J Am Acad Child Adolesc Psychiatry  1987; 26: 728-732.

Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1067-1074

Scheres A, Oosterlaan J, Sergeant JA. Response inhibition in children with AD/HD and other disruptive disorders:the role of behhavioural activation. J Chil Psychol. Psychiatry 2001; 42: 347-357.

Seeman P, Madras BK. Mechanism of drug action. Anti-hyperactivity medication: methylphenidate and amphetamine. Molecular Psychiatry 1998; 3: 386–396

Sergeant JA, Oosterlaan J, Meere JJ. van der. Information processing and energetic factors in attention-deficit/Hyperactivity disorder. In : Quay HC, Hogan (eds)  Handbook of Disruptive Behavior Disorders, Plaenum press, NewYork, pp. 74-104. 1999.

Silberstain RB, Farow M, Levy F et al.. Functional brain electrical activity mapping in boys with attention deficit disorder Arc. Gen. Psychiatry 1998; 55: 1105-1112.

Singer HS, Brown J, Quaskey S, et,al,. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics. 1995; 95: 74-81.

Smalley SL, Bailey JN, Palmer CG, et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998; 3:427-430.

Solanto MV. Neuropharmacological mechanisms of stimulant drug action in attention deficit/hyperactivity disorder: a review and integration. Behavioral Brain Res. 198; 94: 127-152.

Sonuga-Barke EJS, Williams E, Hall M, Saxton T. Hyperactivity and delay aversion. III: the effects on cognitive style of imposing delay after errors. J Child Psychol. Psychiatry 1996, 37, 189-194.

Sonuga-Barke EJS, Dalay D, Thompson M. et al. Parent-based therapies for preschool attention defict hyperactivity disorder: a randomized, controlled trial with a community sample. J. Am. Acad Child Adolesc. Psychiatry  2001; 40: 402-408.

Sonuga-Barke EJS, Dalay D, Thompson M. Does maternalADHD reduce effectiveness of parent trainig for preschool children’s ADHD? J. Am. Acad Child Adolesc. Psychiatry  2002; 41: 696-702.

Spencer T, Biederman J, Heiligenstein J et al. An open-label, dose ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacology 2001; 11: 251-265.

Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention deficit/hyperactivity disorder accross the life-cycle. J Am Acad Child Adolescent Psychiatry 1996; 35: 409+4032.

Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1998; 155: 693-695.

Still GF. TheCoulston lecture on some abnormal physical condition in children. Lancet 1902; 1: 1008-1012.

Stubbe DE, Weiss G. Psychosocial interventions In: Stubbe DE (ed.) Attention-Deficit/Hyperactivity Disorder Child Adolesc. Clin. North America 2000; 9: 663- 670.

Sunohara GA, Roberts W, Malone M, Schachar RJ. Et al. Linkage of the Dopamine D4 receptor gene and attention deficit disorder / hyperactivity disorder. J Am Acad Child Adolescent Psychiatry1999; 39: 1537-1542.

Swanson J.M., Sergeant J.A., Taylor E, et al,. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet  1998; 351, 429-433.

Swanson JM, Castellanos FX, Murias M, LaHoste G, Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr. Op. Neurobiology 1998; 8, 263-271.

Swanson JM,  Wigal S, Greenhill LL. et al. Analog classroom assesment of Adderal in childrenwith ADHD. J Am Acad Child Adolescent Psychiatry 1998; 37: 519-526.

Swanson JM, Volkow N. Pharmacokinetic and pharmacodynamic properties of stimulants: Implications for the design of new treatments for ADHD. 6th Internet World Congress for Biomedical Sciences www.uclm.es/inabis2000/symposia/files/126/index.htm  

Tannock R. Attention deficit hyperactivity disorder: advance in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry  1998; 39: 65-99.

Task Force on promotion and dissemination  of Psychological Procedures. Trainig in and dissemination of empirically validated psychosocial treatment. Report and reccomendation. Clin. Psychol. 1995; 48: 3-24.

Taylor E, Physical treatment. In: Rutter M, Taylor E, Hersov L, eds, Child and Adolescent Psychiatry, Blackwell Science, London, 1994.

Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. J Am Acad Child Adolescent Psychiatry 1996; 35:1213-1216.

Taylor E, Sergeant J, Doepfner M, et al. Clinical guidelines for hyperkinetic disorder. European society for child and adolescent  psychiatry. Eur Child Adolesc Psychiatry 1998; 7: 184-200.

Teicher MH, Anderson CM, Polcari A, Glod CA, Maas LC, Renshaw PF. Funtional defict in basal ganglia of childen with attention-defict/hyperactivity disorder shown with funtional magnetic resonance imaging relaxometry.  Nature Medicine 2000; 4: 470-473.

The Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002;58:527-36.

Thomas GV, Silk AM, An introduction to the psychology of children’s drawings. New York University Press. New York, 1990

Vaidya CJ, Austin G, Kirkorian G, et al. Selective effects of methylphenidate in attention deficit disorder: a functional magnetic resonance study. Proc. Natl.Acad.Sci. USA. 1998; 95: 14494-14499.

Volkow ND, Ding YS, Fowler JS, Wang GJ, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry. 1995; 52:456-63.

Volkow ND Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the Human Brain induced by therapeutic doses of oral methylphenidate. Am J. Psychiatry  1998; 155: 1325-1331.

Volkow ND, Wang G-J, Fowler JS, et al.  Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain.  J. Neurosci. 2001 : RC121*.

Waldman ID, Rowe DC, Abramowitz A, et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J.Hum Genet 1998; 63:1767-76.

Wilens TE, Biederman J, Spencer T. et al.. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1999;156:1931-1937.

Wilens TE, Spencer TJ, Biederman J, et al. A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults. Am J Psychiatry. 2001; 158: 282-288.

Wolraich ML, Greenhill LL, Pelham W et al. Randomized controlled trial of oros methylphenidate once a day in children with for Attention Deficit Hyperactivity Disorder.  Pediatrics 2001; 108: 883-892.

World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines, 10th revision.  Geneva: World Health Organisation; 1992.

Yuan J, McCann U, Ricaurte G. Methylphenidate and brain dopamine neurotoxicity.. Brain Res. 1997; 767:172-5.

Zhuang X., Oosting RS, Jones RS, et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc.Natl.Academy of Science USA 2001; 98:1982-1987.

Zuddas A, Ancilletta B, DeMuro S, Marongiu A, Cianchetti C. Protocollo diagnostico, test di somministrazione acuta e terapia cronica con metilfenidato in bambini con disturbo da deficit attentivo ed iperattività: uno studio pilota. Psichiatria dell'Infanzia e dell'Adolescenza 66: 735-746; 1999.

Zuddas A. Ancilletta B, Muglia P, Cianchetti C. Attention-Deficit/Hyperactivity Disorder: a neuropsychiatric disorder with childhood onset. Eur. J. Paediatric  Neurology 4: 53-62; 2000.


 Bibliografia sugli psicostimolanti


Torna indietro Torna alle Linee Guida

Torna indietro Home